1.1

Aids to access details current report period (2019-20)

1.2

Details of Accountable Authority during the current report period (2019-20)

1.3

Government funding for the supply of blood and blood products, 2010-11 to 2019-20

2.1

Performance Criteria Qualitative Deliverable - provide a safe, secure and affordable supply of blood and blood related products and services

2.2

Performance Criteria Quantitative Deliverable - provide a safe, secure and affordable supply of blood and blood related products and services

2.3

Performance Criteria Qualitative Deliverable - drive performance improvement in the Australian blood sector

2.4

Performance Criteria Qualitative Deliverable - promote a best practice model of management and use of blood and blood related products and services

2.5

Performance Criteria Qualitative Deliverable - develop policy and provide policy advice on the sustainability of the blood sector

2.6

Performance Criteria Qualitative Deliverable - the National Blood Authority is a high performing organisation

2.7

Performance Criteria Quantitative Deliverable - the National Blood Authority is a high performing organisation

2.8

Blood and blood products purchased, by supplier, 2015-16 to 2019-20

2.9

Fresh blood expenditure: increases over the last 10 years

2.10

Immunoglobulin growth

2.11

Lifeblood: selected key performance indicators, 2019-20

2.12

CSL Behring performance under the NaFAA, 2019-20

2.13

Imported Ig: Key performance indicators, by supplier, 2019-20

2.14

Imported plasma and recombinant blood products: key performance indicators, by supplier, 2019-20

3.1

NBA's performance in achieving business plan objectives, 2015-16 to 2019-20

3.2

Australian Public Service Act ongoing employees current report period (2019-20)

3.3

Australian Public Service Act non-ongoing employees current report period (2019-20)

3.4

Australian Public Service Act ongoing employees previous report period (2018-19)

3.5

Australian Public Service Act non-ongoing employees previous report period (2018-19)

3.6

Australian Public Service Act employees by full time and part time status current report period (2019-20)

3.7

Australian Public Service Act employees by full time and part time status previous report period (2018-19)

3.8

Age demographic of NBA staff as at 30 June 2020

3.9

All ongoing employees current report period (2019-20)

3.10

All non-ongoing employees current report period (2019-20)

3.11

All ongoing employees previous report period (2018-19)

3.12

All non-ongoing employees previous report period (2018-19)

3.13

Australian Public Service Act employment type by location current report period (2019-20)

3.14

Australian Public Service Act employment type by location previous report period (2018-19)

3.15

Australian Public Service Act employment arrangements current report period (2019-20)

3.16

Australian Public Service Act employment salary ranges by classification level (minimum/maximum) current report period (2019-20)

3.17

Information about remuneration for key management personnel

3.18

Information about remuneration for senior executives

4.1

Departmental and Administered funding and expenditure 2019-20: a summary

4.2

Key results in financial performance, 2015-16 to 2019-20

4.3

Administered revenue, 2015-16 to 2019-20

4.4

Key results of administered expenses, 2015-16 to 2019-20

4.5

Number and expenditure on consultants current report period (2019-20)

4.6

Expenditure on consultancy services, 2015-16 to 2019-20

5.1

Fresh blood components supplied under contract by Lifeblood, 2019-20

5.2

Plasma and recombinant products supplied under contract 2019-20

5.3

NBA environmental performance indicators

5.4

Agency resource statement

5.5

Agency expenses by outcome

5.6

Report on financial performance summary

5.7

List of requirements